Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $55,903 - $72,975
-1,339 Reduced 20.27%
5,267 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $74,348 - $90,760
1,699 Added 34.62%
6,606 $289,000
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $651 - $772
-14 Reduced 0.28%
4,907 $257,000
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $4,117 - $5,102
-90 Reduced 1.8%
4,921 $254,000
Q3 2021

Oct 29, 2021

SELL
$39.25 - $50.42 $26,297 - $33,781
-670 Reduced 11.79%
5,011 $215,000
Q2 2021

Jul 21, 2021

SELL
$35.91 - $40.68 $15,082 - $17,085
-420 Reduced 6.88%
5,681 $222,000
Q1 2021

May 20, 2021

BUY
$33.49 - $37.77 $10,147 - $11,444
303 Added 5.23%
6,101 $221,000
Q4 2020

Mar 05, 2021

BUY
$33.47 - $42.56 $194,059 - $246,762
5,798 New
5,798 $213,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Patron Partners, LLC Portfolio

Follow Patron Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patron Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patron Partners, LLC with notifications on news.